Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo - PubMed (original) (raw)
. 1995 Sep 1;155(5):2564-70.
Affiliations
- PMID: 7650386
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo
Y Yang et al. J Immunol. 1995.
Abstract
E1-deleted recombinant adenoviruses have been developed for liver-directed gene therapy because efficient gene transfer to hepatocytes can be achieved in vivo. However, these viruses also express viral proteins in hepatocytes, leading to the development of destructive immune responses. Our previous studies indicated that MHC class I-restricted C D8+CTLs are major effectors in eliminating virus-infected cells, and CD4+ cells are also necessary in developing a fully competent CTL response by secretion of IFN-gamma, which sensitizes the virus-infected hepatocytes to CTLs through up-regulation of MHC class I expression. In this study, we have used adoptive transfer techniques in combination with mice deficient in immune functions to further define the role of CD4+ cells in the primary response to adenovirus-mediated gene transfer to the liver. Our studies indicate that CD4+ cells alone are capable of destroying virus-infected hepatocytes. Adoptive transfer experiments with beta 2m- mice along with in vitro CTL assays suggest that these CD4+ can act as CTL effectors, which are MHC class I-restricted. Depletion of these CD4+ effectors in vivo leads to prolongation of adenovirus-mediated transgene expression in hepatocytes. These results suggest that class I-restricted CD4+ CTLs contribute to elimination of adenovirus-transduced hepatocytes and extend our understanding of functional importance of CD4+ cells in viral pathogenesis.
Similar articles
- Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W, Schneider-Rasp S, Liebert U, Merklein F, Thalheimer P, Haack A, Schwaab R, Schmitt C, Brackmann HH. Poller W, et al. Gene Ther. 1996 Jun;3(6):521-30. Gene Ther. 1996. PMID: 8789802 - Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation.
Chen J, Zajac AJ, McPherson SA, Hsu HC, Yang P, Wu Q, Xu X, Wang X, Fujihashi K, Curiel DT, Mountz JD. Chen J, et al. Gene Ther. 2005 Jul;12(13):1079-88. doi: 10.1038/sj.gt.3302494. Gene Ther. 2005. PMID: 15815704 - Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y, Xiang Z, Ertl HC, Wilson JM. Yang Y, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7257-61. doi: 10.1073/pnas.92.16.7257. Proc Natl Acad Sci U S A. 1995. PMID: 7638177 Free PMC article.
Cited by
- Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.
Lee J, Hampl M, Albert P, Fine HA. Lee J, et al. Neoplasia. 2002 Jul-Aug;4(4):312-23. doi: 10.1038/sj.neo.7900245. Neoplasia. 2002. PMID: 12082547 Free PMC article. - Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle LH, Goodall JC, Gaston JS. Boyle LH, et al. Immunology. 2004 May;112(1):54-63. doi: 10.1111/j.1365-2567.2004.01857.x. Immunology. 2004. PMID: 15096184 Free PMC article. - Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.
Schoggins JW, Falck-Pedersen E. Schoggins JW, et al. J Virol. 2006 Nov;80(21):10634-44. doi: 10.1128/JVI.01359-06. Epub 2006 Aug 30. J Virol. 2006. PMID: 16943295 Free PMC article. - RNA interference with special reference to combating viruses of crustacea.
La Fauce K, Owens L. La Fauce K, et al. Indian J Virol. 2012 Sep;23(2):226-43. doi: 10.1007/s13337-012-0084-1. Epub 2012 Aug 14. Indian J Virol. 2012. PMID: 23997446 Free PMC article. - Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure.
Wirtz S, Galle PR, Neurath MF. Wirtz S, et al. Gut. 1999 Jun;44(6):800-7. doi: 10.1136/gut.44.6.800. Gut. 1999. PMID: 10323880 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials